Anika Therapeutics shares owned by Susquehanna International
Quarter-by-quarter ownership of Anika Therapeutics (ANIK) shares owned by Susquehanna International
from 13F filings
Historical chart of Susquehanna International investment in Anika Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Anika Therapeutics held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Anika Therapeutics by Susquehanna International
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $707k | 28k | 25.40 |
2023-09-30 | $983k | 53k | 18.63 |
2023-06-30 | $208k | 8.0k | 25.98 |
2023-03-31 | $853k | 30k | 28.72 |
2022-12-31 | $1.5M | 50k | 29.60 |
2022-09-30 | $1.6M | 68k | 23.83 |
2022-03-31 | $785k | 31k | 25.14 |
2021-12-31 | $504k | 14k | 35.84 |
2021-09-30 | $865k | 20k | 42.52 |
2021-06-30 | $324k | 7.5k | 43.23 |
2021-03-31 | $1.3M | 31k | 40.76 |
2020-12-31 | $2.1M | 47k | 45.34 |
2020-09-30 | $323k | 9.1k | 35.39 |
2020-06-30 | $2.4M | 64k | 37.68 |
2020-03-31 | $2.5M | 88k | 28.90 |
2019-12-31 | $8.6M | 165k | 51.85 |
2019-09-30 | $7.0M | 127k | 54.90 |
2019-06-30 | $1.5M | 36k | 40.68 |
2019-03-31 | $2.5M | 83k | 30.23 |
2018-12-31 | $1.2M | 35k | 33.62 |
2018-09-30 | $5.6M | 133k | 42.17 |
2018-06-30 | $6.4M | 201k | 31.97 |
2018-03-31 | $3.2M | 64k | 49.72 |
2017-12-31 | $559k | 10k | 53.89 |
2017-09-30 | $2.2M | 38k | 58.00 |
2017-06-30 | $2.9M | 58k | 49.35 |
2017-03-31 | $2.2M | 50k | 43.43 |
2016-12-31 | $2.7M | 54k | 48.96 |
2016-09-30 | $2.5M | 53k | 47.86 |
2016-06-30 | $4.3M | 81k | 53.65 |
2016-03-31 | $5.4M | 122k | 44.72 |
2015-12-31 | $4.9M | 129k | 38.16 |
2015-09-30 | $6.1M | 192k | 31.81 |
2015-06-30 | $6.7M | 204k | 33.03 |
2015-03-31 | $4.1M | 99k | 41.15 |
2014-12-31 | $6.6M | 161k | 40.75 |
2014-09-30 | $7.3M | 198k | 36.66 |
2014-06-30 | $7.0M | 152k | 46.32 |
2014-03-31 | $5.6M | 136k | 41.09 |
2013-12-31 | $1.8M | 46k | 38.13 |
2013-09-30 | $220k | 9.2k | 23.91 |